12 reports

  • Cough and Cold Medicine
  • Cough and Cold Medicine Sales Volume and Market Share
  • Cough Cold
  • China
  • Demand
  • Market Size
  • Trade
  • Cough and Cold Medicine
  • Cough and Cold Medicine Producers
  • Cough Cold
  • China
  • Demand
  • Market Size
  • Trade

Cough/ Cold Remedies - Market Trends & Insights ##.

  • Cough Cold
  • OTC
  • United States
  • Demand
  • Market Shares
  • RECKITT BENCKISER (US COUGH AND COLD OTC MEDICINE SALES) - FINANCIAL PERFORMANCE*
  • PFIZER (US OTC COUGH AND COLD MEDICINE SALES) - FINANCIAL PERFORMANCE
  • Cough Cold
  • United States
  • Demand
  • Pfizer Inc.
  • Reckitt Benckiser Group plc
  • Sales Per Capita of Select CCA Products and Y-o-Y % Growth of CCA Category 2011-2016
  • What do consumers take when they get sick?

Generally, among flu-related medicines, US consumers spend the most per capita on combination cough, cold and allergy products.

  • Cough Cold
  • Influenza
  • United States
  • Demand
  • Mondelez International, Inc.
  • COLD MEDICINE SALES AND FORECASTS (BILLION YUAN)
  • Cough Medicine
  • Cardiovascular Drug
  • Cough Cold
  • China
  • Demand
  • Market Size

To this end, RB has aggressively pursued acquisitions in the consumer health industry, including the US dietary supplement producer Schiff in late 2012 and the Chinese cough, cold and allergy (hay fever) remedies specialist Shanxi Guilong Medicine in February 2013 and partnership with Brist

  • Cough Cold
  • World
  • Demand
  • Reckitt Benckiser Group plc
  • Schiff Nutrition International, Inc.

COMPETITIVE LANDSCAPE.............. ## Cough & Cold Medication.............. ## Table ##: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC Worldwide (2015) - Percentage Share Breakdown by Value for Johnson & Johnson, Procter & Gamble Co., and Othe

  • Cough Cold
  • Australia
  • United States
  • World
  • Market Shares
  • Allergy, Cough, Cold, and Sinus Products
  • Three: Allergy, Cough, Cold, and Sinus Products
  • Cough Cold
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Nasopharyngitis (Common Cold) - Pipeline by Vernalis Plc, H1 2017

(" Tris" ) for the US prescription cough-cold market.

  • Cough Cold
  • Respiratory Disease
  • United States
  • World
  • Product Initiative
  • Featured News & Press Releases
  • Mechanism Of Action R&D Progress
  • Cough Cold
  • United States
  • World
  • Product Initiative
  • Vernalis plc
  • LICENSING AGREEMENTS

It offers medical devices for dermatology, allergy, cough and cold; airway diseases and dry epithelia applications.

  • Cough Cold
  • Germany
  • Company
  • Deals & Alliance
  • GlobalData's company